PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.97%
Revenue growth under 50% of ON's 13.09%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
4.03%
Gross profit growth under 50% of ON's 17.99%. Michael Burry would be concerned about a severe competitive disadvantage.
16.31%
Positive EBIT growth while ON is negative. John Neff might see a substantial edge in operational management.
12.45%
Positive operating income growth while ON is negative. John Neff might view this as a competitive edge in operations.
207.84%
Positive net income growth while ON is negative. John Neff might see a big relative performance advantage.
204.00%
Positive EPS growth while ON is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
200.00%
Positive diluted EPS growth while ON is negative. John Neff might view this as a strong relative advantage in controlling dilution.
4.94%
Share reduction more than 1.5x ON's 17.04%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.32%
Diluted share reduction more than 1.5x ON's 16.50%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-7.43%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
59.20%
OCF growth under 50% of ON's 170.73%. Michael Burry might suspect questionable revenue recognition or rising costs.
136.40%
FCF growth 50-75% of ON's 234.19%. Martin Whitman would see if structural disadvantages exist in generating free cash.
36.04%
10Y CAGR of 36.04% while ON is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-23.23%
Negative 5Y CAGR while ON stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-0.63%
Negative 3Y CAGR while ON stands at 0.00%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
277.93%
OCF/share CAGR of 277.93% while ON is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
42.76%
OCF/share CAGR of 42.76% while ON is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-5.23%
Negative 3Y OCF/share CAGR while ON stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
8874.99%
10Y net income/share CAGR of 8874.99% while ON is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
307.63%
Net income/share CAGR of 307.63% while ON is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
365.54%
3Y net income/share CAGR of 365.54% while ON is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
292.02%
Equity/share CAGR of 292.02% while ON is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
211.37%
Equity/share CAGR of 211.37% while ON is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
153.92%
Equity/share CAGR of 153.92% while ON is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
7.92%
Dividend/share CAGR of 7.92% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
29.26%
Dividend/share CAGR of 29.26% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-7.85%
Negative near-term dividend growth while ON invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
9.79%
AR growth well above ON's 13.72%. Michael Burry fears inflated revenue or higher default risk in the near future.
8.75%
Inventory growth well above ON's 8.71%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
11.76%
Asset growth at 50-75% of ON's 15.97%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
7.81%
Under 50% of ON's 3143.34%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-1.82%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.25%
Our R&D shrinks while ON invests at 52.68%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
3.09%
SG&A declining or stable vs. ON's 21.53%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.